文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

靶向肺癌中的铁死亡调节因子:探索天然产物

Targeting ferroptosis regulators in lung cancer: Exploring natural products.

作者信息

Yuhao Wang, Shenghua Cheng, Jueying Chen, Shate Xiang, Rongrong Song, Xiangfeng Shen

机构信息

Graduated College, Jiangxi University of Chinese Medicine, Nanchang, 330000, Jiangxi, China.

First Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou, 310053, Zhejiang, China.

出版信息

Heliyon. 2024 Jul 2;10(14):e33934. doi: 10.1016/j.heliyon.2024.e33934. eCollection 2024 Jul 30.


DOI:10.1016/j.heliyon.2024.e33934
PMID:39104501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11298827/
Abstract

Lung cancer remains a formidable global health challenge, necessitating innovative therapeutic strategies for improved efficacy. This review explores the untapped potential of natural products and Traditional Chinese Medicine (TCM) in lung cancer therapy, focusing on targeting ferroptosis regulators. Natural compounds, such as curcumin and resveratrol, exhibit diverse anti-cancer mechanisms, complemented by TCM's holistic approach rooted in a 3500-year history. Emphasizing the induction of cell death, particularly ferroptosis, the review highlights its significance in overcoming challenges like resistance to conventional therapies. Key ferroptosis regulators are explored in the context of natural products and TCM. The impact of these treatments on crucial pathways, such as antioxidant mechanisms (GPX4, SLC7A11, and NRF2), iron metabolism regulators, and lipid and mitochondria pathways, is examined. The findings provide a comprehensive overview of how natural products and TCM modulate ferroptosis in lung cancer, offering valuable insights for the development of innovative, side-effect-reduced therapeutic strategies. This work holds promise for transforming the landscape of lung cancer treatment by integrating the rich resources of nature into conventional therapeutic paradigms.

摘要

肺癌仍然是一项严峻的全球健康挑战,需要创新的治疗策略来提高疗效。本综述探讨了天然产物和中药在肺癌治疗中尚未开发的潜力,重点关注靶向铁死亡调节因子。姜黄素和白藜芦醇等天然化合物具有多种抗癌机制,而拥有3500年历史的中医整体疗法也对其起到补充作用。本综述强调诱导细胞死亡,特别是铁死亡,突出了其在克服对传统疗法耐药等挑战方面的重要性。在天然产物和中药的背景下,对关键的铁死亡调节因子进行了探讨。研究了这些治疗方法对关键途径的影响,如抗氧化机制(GPX4、SLC7A11和NRF2)、铁代谢调节因子以及脂质和线粒体途径。这些发现全面概述了天然产物和中药如何调节肺癌中的铁死亡,为开发创新的、副作用更小的治疗策略提供了有价值的见解。通过将丰富的自然资源整合到传统治疗模式中,这项工作有望改变肺癌治疗的局面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66b/11298827/16f6f5c7a6b6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66b/11298827/a4b30e96dac2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66b/11298827/d27c6dd26ce4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66b/11298827/a23f4278b6dd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66b/11298827/16f6f5c7a6b6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66b/11298827/a4b30e96dac2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66b/11298827/d27c6dd26ce4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66b/11298827/a23f4278b6dd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d66b/11298827/16f6f5c7a6b6/gr4.jpg

相似文献

[1]
Targeting ferroptosis regulators in lung cancer: Exploring natural products.

Heliyon. 2024-7-2

[2]
Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases.

Phytomedicine. 2024-7-25

[3]
Targeting ferroptosis regulators by natural products in colorectal cancer.

Front Pharmacol. 2024-5-27

[4]
Recent advances in the potential effects of natural products from traditional Chinese medicine against respiratory diseases targeting ferroptosis.

Chin Med. 2024-3-22

[5]
A review on the research progress of traditional Chinese medicine with anti-cancer effect targeting ferroptosis.

Chin Med. 2023-10-13

[6]
Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review.

Front Pharmacol. 2024-5-1

[7]
Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.

Phytomedicine. 2024-1

[8]
Ferroptosis: a new mechanism of traditional Chinese medicine for treating ulcerative colitis.

Front Pharmacol. 2024-6-4

[9]
Ferroptosis: a new mechanism of traditional Chinese medicine for cancer treatment.

Front Pharmacol. 2024-1-16

[10]
Induction of ferroptosis by natural phenols: A promising strategy for cancer therapy.

Phytother Res. 2024-4

引用本文的文献

[1]
The YY1-ABCB7 regulatory Axis is associated with malignant progression and ferroptosis sensitivity in lung adenocarcinoma.

J Mol Histol. 2025-8-6

[2]
Molecular Alterations in Ferroptosis and the Effects of Resveratrol: A Systematic Review.

J Biochem Mol Toxicol. 2025-7

[3]
Ethyl Acetate Extract of Vaniot Attenuates Oxidative Stress in ALI Mice.

J Inflamm Res. 2025-6-6

[4]
Crocin promotes ferroptosis in gastric cancer via the Nrf2/GGTLC2 pathway.

Front Pharmacol. 2025-3-21

[5]
Natural ingredients in the regulation of abnormal lipid peroxidation: a potential therapy for pulmonary diseases.

Front Pharmacol. 2024-12-20

本文引用的文献

[1]
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.

Signal Transduct Target Ther. 2024-3-8

[2]
NRF2 promotes radiation resistance by cooperating with TOPBP1 to activate the ATR-CHK1 signaling pathway.

Theranostics. 2024

[3]
Monaspin B, a Novel Cyclohexyl-furan from Cocultivation of and , Exhibits Potent Antileukemic Activity.

J Agric Food Chem. 2024-1-17

[4]
Pseudolaric acid B triggers ferritinophagy and ferroptosis via upregulating NCOA4 in lung adenocarcinoma cells.

J Cancer Res Ther. 2023-12-1

[5]
Targeting Ferroptosis as a Therapeutic Implication in Lung Cancer Treatment by a Novel Naphthoquinone Inducer: Juglone.

Mol Biotechnol. 2024-5

[6]
Gigantol exerts anti-lung cancer activity by inducing ferroptosis via SLC7A11-GPX4 axis.

Biochem Biophys Res Commun. 2024-1-1

[7]
FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancer.

Biomed Pharmacother. 2023-12-31

[8]
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance.

Cell Rep. 2023-11-28

[9]
Mechanisms and regulations of ferroptosis.

Front Immunol. 2023

[10]
Sclareol induces cell cycle arrest and ROS-mediated apoptosis and ferroptosis in lung adenocarcinoma cells.

J Biochem Mol Toxicol. 2024-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索